Gene therapy for liver tumors

Surgical Oncology Clinics of North America

Volumn 5, Issue 2, 1996, Pages 461-473

  Panis, Y ^a   Rad, A R K ^a   Boyer, O ^a   Houssin, D ^a   Salzmann, J L ^a   Klatzmann, D ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYTOKINE; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; INTERLEUKIN 2; PROTEIN P53; THYMIDINE KINASE;

ADENOVIRUS; CLINICAL TRIAL; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HUMAN; IMMUNOSTIMULATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; NONHUMAN; RETROVIRUS; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0029985488     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30395-8     Document Type: Review

References (63)

1. Anderson W.F. McGarrity G.J. Moen R.C. Report to the NIH Recombinant DNA Advisory Committee on murine replication-competent retrovirus (RCR) assays (February 17, 1993) Human Gene Therapy 4 1993 311
2. Asher A.L. Mule J.J. Kasid A. Murine tumor cells transduced with the gene for tumor necrosis factor-alpha: Evidence for paracrine immune effects of tumor necrosis factor against tumors J Immunol 146 1991 3227
3. Baker S.J. Markowitz S. Fearon E.R. Suppression of human colorectal carcinoma cell growth by wild-type p53 Science 249 1990 912
4. Barba D. Hardin J. Sadelain M. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors Proc Natl Acad Sci USA 91 1994 4348
5. Bi W.L. Parysek L.M. Warnick R. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy Human Gene Therapy 4 1993 725
6. Branchereau S. Calise D. Ferry N. Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo Human Gene Therapy 5 1994 803
7. Caruso M. Klatzmann D. Selective killing of CD4 + cells harboring a human immuno-deficiency virus-inducible suicide gene prevents viral spread in an infected cell population Proc Natl Acad Sci USA 89 1992 182
8. Caruso M. Panis Y. Gagandeep S. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene Proc Natl Acad Sci USA 90 1993 7024
9. Chang A.G. Wu G.Y. Gene therapy: Applications to the treatment of gastrointestinal and liver diseases Gastroenterology 106 1994 1076
10. Chen S.H. Chen X.H. Wang Y. Combination gene therapy for liver metastasis of colon carcinoma in vivo Proc Natl Acad Sci USA 92 1995 2577
11. Chen S.H. Shine H.D. Goodman J.C. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo Proc Natl Acad Sci USA 91 1994 3054
12. Ciardiello F. Tortora G. Bianco C. Inhibition of CRIPTO expression and tumori-genicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides Oncogene 9 1994 291
13. Clayman G.L. el-Naggar A.K. Roth J.A. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma Cancer Res 55 1995 1
14. Colombo M.P. Ferrari G. Stoppacciaro A. Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo J Exp Med 173 1991 889
15. Cornetta K. Morgan R.A. Anderson W.F. Safety issues related to retroviral-mediated gene transfer in humans Human Gene Therapy 2 1991 5
16. Cornetta K. Morgan R.A. Gillio A. No retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic retrovirus Human Gene Therapy 2 1991 215
17. Culver K.W. Ram Z. Wallbridge S. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors Science 256 1992 1550
18. Dranoff G. Jaffee E. Lazenby A. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 90 1993 3539
19. Drazan K.E. Shen X.D. Csete M.E. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection Surgery 116 1994 197
20. Ezzeddine Z.D. Martuza R.L. Platika D. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene New Biology 3 1991 608
21. Fairbairn L.J. Cross M.A. Arrand J.R. Paterson symposium 1993: Gene therapy Br J Cancer 69 1994 972
22. Fearon E.R. Pardoll D.M. Itaya T. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response Cell 60 1990 397
23. Felgner P. Zaugg R. Norman J. Synthetic recombinant DNA delivery for cancer therapeutics Cancer Gene Therapy 2 1995 61
24. Ferry N. Duplessis O. Houssin D. Retroviral-mediated gene transfer into hepato-cytes in vivo Proc Natl Acad Sci USA 88 1991 8377
25. Fisher D.E. Apoptosis in cancer therapy: Crossing the threshold Cell 78 1994 539
26. Gansbacher B. Bannerji R. Daniels B. Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity Cancer Res 50 1990 7820
27. Golumbek P.T. Lazenby A.J. Levitsky H.I. Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4 Science 254 1991 713
28. Harris C.C. Hollstein M. Clinical implications of the p53 tumor-suppressor gene N Engl J Med 329 1993 1318
29. Herz J. Gerard R.D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice Proc Natl Acad Sci USA 90 1993 2812
30. Hickman M.A. Malone R.W. Lehmann B.K. Gene expression following direct injection of DNA into liver Human Gene Therapy 5 1994 1477
31. Huber B.E. Austin E.A. Richards C.A. Metabolism of 5-fluorocytosine to 5-fluoro-uracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase Proc Natl Acad Sci USA 91 1994 8302
32. Huber B.E. Richards C.A. Krenitsky T.A. Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: An innovative approach for cancer therapy Proc Natl Acad Sci USA 88 1991 8039
33. Jolly D. Viral vectors for gene therapy Cancer Gene Therapy 1 1994 51
34. Kay M.A. Li Q. Liu T.J. Hepatic gene therapy: Persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo Human Gene Therapy 3 1992 641
35. Kimura O. Yamaguchi Y. Gunning K.B. Retroviral delivery of DNA into the livers of transgenic mice bearing premalignant and malignant hepatocellular carcinomas Human Gene Therapy 5 1994 845
36. Kuriyama S. Yoshikawa M. Ishizaka S. A potential approach for gene therapy targeting hepatoma using a liver-specific promoter on a retroviral vector Cell Struct Funct 16 1991 503
37. Ledley F.D. Hepatic gene therapy: Present and future Hepatology 18 1993 1263
38. Lowe S.W. Ruley H.E. Jacks T. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents Cell 74 1993 957
39. Lyerly H.K. DiMaio J.M. Gene delivery systems in surgery Arch Surg 128 1993 1197
40. Macri P. Gordon J.W. Delayed morbidity and mortality of albumin/SV40 T-antigen transgenic mice after insertion of an alpha-fetoprotein/herpes virus thymidine kinase transgene and treatment with ganciclovir Human Gene Therapy 5 1994 175
41. Mercola D. Cohen J. Antisense approach to cancer gene therapy Cancer Gene Therapy 2 1995 47
42. Michaels M.G. Green M. Wald E.R. Adenovirus infection in pediatric liver transplant recipients J Infect Dis 165 1992 170
43. Miller D.G. Adam M.A. Miller A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection Mol Cell Biol 10 1990 4239
44. Moolten F. Drug sensitivity (“suicide”) gene for selective cancer chemotherapy Cancer Gene Therapy 1 1994 279
45. Moolten F.L. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy Cancer Res 46 1986 5276
46. Moolten F.L. Cupples L.A. A model for predicting the risk of cancer consequent to retroviral gene therapy Human Gene Therapy 3 1992 479
47. Moolten F.L. Wells J.M. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors J Natl Cancer Inst 82 1990 297
48. Nabel G. Chang A. Nabel E. Clinical protocol: Immunotherapy of malignancy by in vitro gene transfer into tumors Human Gene Therapy 3 1992 399
49. Panis Y. Caruso M. Houssin D. Traitement de tumeurs hepatiques experimentales par transfert de gene suicide in vivo chez le rat C R Acad Sci (Paris) 315 1992 541
50. Panis Y. Ribeiro J. Chretien Y. Dormant liver metastases: An experimental study Br J Surg 79 1992 221
51. Pappo I. Tahara H. Robbins P.D. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy J Surg Res 58 1995 218
52. Pardoll D.M. Cancer vaccines Immunol Today 14 1993 310
53. Plautz G.E. Yang Z.Y. Wu B.Y. Immunotherapy of malignancy by in vivo gene transfer into tumors Proc Natl Acad Sci USA 90 1993 4645
54. Ratajczak M.Z. Kant J.A. Luger S.M. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides Proc Natl Acad Sci USA 89 1992 11823
55. Rosenberg S.A. Anderson W.F. Blaese M. The development of gene therapy for the treatment of cancer Ann Surg 218 1993 455
56. Scheele J. Stangl R. Altendorf H.A. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history Br J Surg 77 1990 1241
57. Shaw P. Bovey R. Tardy S. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line Proc Natl Acad Sci USA 89 1992 4495
58. Sikora K. First 5 years of gene therapy for cancer Lancet 344 1994 1631
59. Stratford P.L. Levrero M. Chasse J.F. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector Human Gene Therapy 1 1990 241
60. Tahara H. Zeh H3. Storkus W.J. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo Cancer Res 54 1994 182
61. Tapscott S.J. Miller A.D. Olson J.M. Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection Proc Natl Acad Sci USA 91 1994 8185
62. Wei M.X. Tamiya T. Chase M. Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene Human Gene Therapy 5 1994 969
63. Yang Y. Nunes F.A. Berencsi K. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy Proc Natl Acad Sci USA 91 1994 4407